⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PLX News
Protalix BioTherapeutics, Inc. Common Stock
Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025
prnewswire.com
PLX
Bronstein, Gewirtz & Grossman, LLC Encourages Protalix BioTherapeutics, Inc. (PLX) Shareholders to Inquire about Securities Investigation
accessnewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
Bronstein, Gewirtz & Grossman, LLC Is Investigating Protalix BioTherapeutics, Inc. (PLX) And Encourages Shareholders to Connect
accessnewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Protalix BioTherapeutics, Inc. (PLX) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
PLX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Protalix BioTherapeutics, Inc. (PLX) And Encourages Shareholders to Reach Out
accessnewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
businesswire.com
PLX